Biological Activity, Phytochemical Prospective and Bioefficiency of Plant Species

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 1099

Special Issue Editors

E-Mail Website
Guest Editor
Research Institute of Integrative Life Sciences, Dongguk University, Goyang-si, Korea
Interests: antioxidant activity; medicinal plants; functional foods; plant stress; green synthesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Traditional resources have been a boon for knowledge and provide multiple healing methods that have become beneficial in treating many diseases worldwide. Natural products have been utilized as a biological action modifier, employed mostly with regard to phytochemical studies. Continuous study over the years and the research and analysis of natural products have led to the present day possibility of isolating compounds from natural products and the formation of ubiquitous pharmaceutical products that have demonstrated upright market significance and the ability to treat various diseases. In their early days, drug discovery studies were performed via the identification of the active ingredient, either from natural resources or due to coincidental discovery. Modern drug discovery focuses on the identification and screening of compounds and their optimization in order to enhance their affinity, selectivity, bioavailability and metabolic stability; this further enhances our understanding of how infection and the diseases caused are regulated at the molecular and physiological stages, and enables us to target the specific materials based on the guided knowledge. Currently, bioactive compounds of plant origin have been, and remain, a vital source for modern drug industries. In the last 20 years, the FDA has approved one-third of drugs that are based on natural plant-based resources. Such innovations in the development of drugs based on natural products have initiated a revolutionary period. From labs to pharmaceutical industries, compounds derived or isolated from plants are employed either directly or indirectly in manufacturing various types of medicine. This is the case because the chemical synthesis of some compounds is either not possible or is not economically viable. Due to the therapeutic potentiality of natural products, the scrutinization of novel drugs and their fabrication from plant resources experience certain difficulties due to the intricacy of the molecular mixtures. Some medicinal plants take several years to grow or cannot be produced in certain climatic conditions using seeds or vegetative propagation. Plant tissue culture plays an essential role in the protection and mass production of these plants.

While in recent years the enormous progress of nanotechnology in biomedical sciences has revolutionized therapeutic and diagnostic approaches, the understanding of nanoparticle–plant interactions, including uptake, mobilization and accumulation, is still in its infancy. Deeper studies are needed in order to establish the impact of nanomaterials (NMs) on plant growth and agro-ecosystems and to develop smart nanotechnology applications in crop improvement. Therefore, it is vital to keep speed with the advancement of research in the field of plants and their biotechnological and nanotechnological applications. This current Special Issue will provide a platform for generating discussion pertaining to the recent advancements in the field of phytochemicals and their biological activities, as well as their amalgamation with advanced biotechnology and nanotechnology, in the form of research and review articles contributed by eminent experts throughout the world.

Dr. Jayanta Kumar Patra
Dr. Gitishree Das
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • biological activities and bioefficiency
  • plant tissue culture, propagation and bioreactor technology
  • micropropagation, and production of useful secondary metabolites
  • hydroponics study on plants
  • bibliometric analysis
  • plant breeding
  • phytopharmaceutical drugs from traditional resources
  • modern drug discovery
  • pharmacology and pharmacognosy
  • plant secondary metabolites
  • nanotechnology and plants

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


14 pages, 317 KiB  
The In Vitro Inhibitory Activity of Pacaya Palm Rachis versus Dipeptidyl Peptidase-IV, Angiotensin-Converting Enzyme, α-Glucosidase and α-Amylase
by Aurea Bernardino-Nicanor, Stephanie Fernández-Avalos, José Mayolo Simitrio Juárez-Goiz, José Luis Montañez-Soto and Leopoldo González-Cruz
Plants 2024, 13(3), 400; - 29 Jan 2024
Viewed by 647
The pacaya palm (Chamaedorea tepejilote Liebm) is an important food that is commonly consumed in Mexico and Central America due to its nutritive value. It is also used as a nutraceutical food against some chronic diseases, such as hypertension and hyperglycemia. However, [...] Read more.
The pacaya palm (Chamaedorea tepejilote Liebm) is an important food that is commonly consumed in Mexico and Central America due to its nutritive value. It is also used as a nutraceutical food against some chronic diseases, such as hypertension and hyperglycemia. However, few reports have indicated its possible potential. For this reason, the goal of this research was to evaluate the effects of the enzymatic activity of the pacaya palm inflorescence rachis on both hypertension and hyperglycemia and the effects of thermal treatments on the enzymatic activity. The enzymatic inhibition of ACE (angiotensin-converting enzyme), DPP-IV (dipeptidyl peptidase-IV), α-glucosidase and α-amylase were evaluated, all with powder extracts of pacaya palm inflorescences rachis. The results indicated that thermally treated rachis showed increased enzymatic inhibitory activity against α-amylase and DPP-IV. However, all rachis, both with and without thermal treatment, showed low- or no enzymatic activity against α-glucosidase and ACE. Apparently, the mechanism of action of the antidiabetic effect of rachis is mediated by the inhibition of α-amylase and DPP-IV and does not contribute with a significant effect on enzymes involved in the hypertension mechanism. Finally, the properties of the extract were modified via the extraction method and the temperature tested. Full article
Back to TopTop